1-8 of 8
Steven Bernstein
Close
Sort by
Journal Articles

A Patient-Derived Xenograft Model of Marginal Zone and Follicular Lymphomas Demonstrates a Key Role of CD4+ T Cells

Richard Burack, MD PhD, Gautam Shenoy, PhD, Janice M. Spence, PhD, Stephen Spence, Phillip Rock, Lenny Shultz, Richard Bankert, Steven Bernstein
Journal: Blood
Blood (2016) 128 (22): 916.
https://doi.org/10.1182/blood.V128.22.916.916
Published: 2016
Journal Articles

An IHC Screen for EphA3 Positive Myelofibrosis (MF) and Other Myeloproliferative Neoplasms (MPNs)

Darren Locke, PhD, Frank Lynch, PhD, Steven Bernstein, PhD, Koushan Siami-Namini, MD FCAP, Geoff T Yarranton, PhD
Journal: Blood
Blood (2014) 124 (21): 5588.
https://doi.org/10.1182/blood.V124.21.5588.5588
Published: 2014
Journal Articles

An IHC Screen For EphA3 Positive FFPE Tumors

Darren Locke, PhD, Steven Bernstein, PhD, Frank Lynch, PhD, Koushan Siami-Namini, MD, FCAP, Jackie M. Walling, MBChB, PhD, Thomas Yonker, Geoffrey Yarranton, PhD
Journal: Blood
Blood (2013) 122 (21): 4965.
https://doi.org/10.1182/blood.V122.21.4965.4965
Published: 2013
Journal Articles

Effect of Prior Rituximab on Residence Time of I131 Tositumomab Consolidation Therapy in Patients (pts) with Non Hodgkin’s Lymphoma (NHL): Analysis of SWOG Clinical Trials.

Julia Schaefer-Cutillo, Vaseem Chengazi, Derick R Peterson, David G. Maloney, Kevin Kibler, Erin Cebula, Steven Bernstein, Faith Young, Oliver W. Press, Lisa M. Rimsza, Richard I. Fisher, Jonathan W. Friedberg, MD
Journal: Blood
Blood (2008) 112 (11): 2000.
https://doi.org/10.1182/blood.V112.11.2000.2000
Published: 2008
Journal Articles

Bortezomib and Gemcitabine in Relapsed Hodgkin Lymphoma (HL).

Jonathan W. Friedberg, Jennifer Kelly, Susan Voci, Diana Marquis, Lynn Rich, Randall Rossi, Steven Bernstein, Craig Jordan, Jane Liesveld, Richard I. Fisher
Journal: Blood
Blood (2007) 110 (11): 2325.
https://doi.org/10.1182/blood.V110.11.2325.2325
Published: 2007
Journal Articles

Durable Responses with Bortezomib in Patients with Relapsed or Refractory Mantle Cell Lymphoma (MCL): Updated Time-to-Event Analyses of the Multicenter PINNACLE Study.

Andre Goy, Steven Bernstein, Brad Kahl, Benjamin Djulbegovic, Michael Robertson, Sven de Vos, Elliot Epner, Amrita Krishnan, John Leonard, Sagar Lonial, Edward Stadtmauer, Owen O’Connor, Hongliang Shi, Anthony Boral, Richard Fisher
Journal: Blood
Blood (2007) 110 (11): 125.
https://doi.org/10.1182/blood.V110.11.125.125
Published: 2007
Journal Articles

Phase II Study of SGN-30 (Anti-CD30 Monoclonal Antibody) in Patients with Refractory or Recurrent Hodgkin’s Disease.

John P. Leonard, M.D., Joseph D. Rosenblatt, M.D., Nancy L. Bartlett, M.D., Ajay Gopal, M.D., Anas Younes, M.D., David Fisher, M.D., Francine Foss, M.D., Andres Forero, M.D., Steven Bernstein, M.D., Bruce Cheson, M.D., Matthew H. Carabasi, M.D., R. Gregory Bociek, M.D., Bruce Hart, Ph.D., Michael McDonald, M.D.
Journal: Blood
Blood (2004) 104 (11): 2635.
https://doi.org/10.1182/blood.V104.11.2635.2635
Published: 2004
Journal Articles

SGN-30 (Anti-CD30 Monoclonal Antibody) Is Active and Well Tolerated in Patients with Refractory or Recurrent Systemic Anaplastic Large Cell Lymphoma.

Andres Forero-Torres, Steven Bernstein, Ajay Gopal, Francine Foss, John Leonard, Joseph Rosenblatt, Nancy Bartlett, Anas Younes, David Fisher, Bruce Cheson, Matthew Carabasi, Gregory Bociek, Bruce Hart, Michael McDonald
Journal: Blood
Blood (2004) 104 (11): 2637.
https://doi.org/10.1182/blood.V104.11.2637.2637
Published: 2004